Compare VABK & KRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VABK | KRMD |
|---|---|---|
| Founded | 1998 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 231.3M | 189.3M |
| IPO Year | 2013 | 2019 |
| Metric | VABK | KRMD |
|---|---|---|
| Price | $42.60 | $3.96 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $6.50 |
| AVG Volume (30 Days) | 4.4K | ★ 122.7K |
| Earning Date | 04-23-2026 | 05-06-2026 |
| Dividend Yield | ★ 3.39% | N/A |
| EPS Growth | 12.70 | ★ 53.85 |
| EPS | ★ 0.97 | N/A |
| Revenue | N/A | ★ $41,127,366.00 |
| Revenue This Year | N/A | $20.32 |
| Revenue Next Year | N/A | $17.37 |
| P/E Ratio | $43.40 | ★ N/A |
| Revenue Growth | N/A | ★ 22.23 |
| 52 Week Low | $36.37 | $2.63 |
| 52 Week High | $48.58 | $6.61 |
| Indicator | VABK | KRMD |
|---|---|---|
| Relative Strength Index (RSI) | 53.12 | 45.56 |
| Support Level | $38.18 | $3.88 |
| Resistance Level | $43.98 | $4.34 |
| Average True Range (ATR) | 1.09 | 0.18 |
| MACD | -0.23 | -0.01 |
| Stochastic Oscillator | 15.79 | 17.05 |
Virginia National Bankshares Corp is a bank holding company engaged in commercial and retail banking. The bank offers a range of banking and related financial services, including checking accounts, negotiable order of withdrawal accounts, money market deposit accounts, certificates of deposit, individual retirement accounts, and other depository services. Its segments include the Bank, VNB Trust and Estate Services, and Masonry Capital. The Bank's commercial banking activities involve making loans, taking deposits, and offering related services to individuals, businesses, and charitable organizations.
KORU Medical Systems Inc develops, manufactures, and commercializes large volume subcutaneous infusion solutions for the subcutaneous drug delivery market. Its product portfolio focuses on mechanical infusion devices, including the FREEDOM60 and FreedomEdge syringe drivers, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company operates as one segment. Its revenue streams are: Domestic Core, International Core and Pharma services and clinical trials. The majority of the company's revenue is derived from the Domestic Core business, which consists of sales of its syringe drivers, tubing and needles. Geographically, its revenues are predominantly derived from the United States.